Singapore’s co-developed vaccine candidate is in ‘good shape’ for delivery in 2021 (CNBC)

A COVID-19 vaccine candidate co-developed by Singapore scientists has shown positive interim results and could be available as early as 2021. That’s according to American biopharmaceutical firm Arcturus Therapeutics, which is working with scientists from Duke-NUS Medical School in Singapore, to develop the vaccine.